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Signal Transduction Mechanisms Involved in
Hormonal Ca2+ Fluxes
By John R. Williamson* and Jonathan R. Monck*
This article reviews literature up to mid-1988 covering recent developments pertaining to ago-
nist-induced Ca2` signaling in various cell types. A large amount of experimental evidence sup-
ports a mechanism involving specific guanine nucleotide-binding proteins (G-proteins) as
transducing factors between occupancy of a wide variety of receptors by many different agonists
and activation of polyphosphoinositide specific phospholipase C enzymes. Although many differ-
ent G-proteins and phospholipase C enzymes have been purified and cloned, successful reconstitu-
tion of the components has not been achieved. Hence, many questions concerning the specificity
of coupling between particular receptors to a particular G-protein and phospholipase C subtype
remain unresolved. Phospholipase C subtypes isolated from the membrane and soluble fractions
of the cell are directly activated by Ca2" and, preferentially, hydrolyse phosphatidylinositol 4,5-
bisphosphate (PIP2) and phosphatidylinositol 4-phosphate (PIP). The role of the G-protein is to
stimulate inositol lipid breakdown at free Ca2' concentrations (0.1-0.2 FM) typical of unstimu-
lated cells. Overwhelming evidence supports the concept that Ins 1,4,5-P3, the product of PIP2
hydrolysis, is responsible for the initial agonist-induced Ca2' transient by mobilization of Ca2+
from a specialized intracellular store. An Ins 1,4,5-P3 receptor has been purified that may corre-
spond to the postulated Ins 1,4,5-P8 gated Ca21 channel. Despite a growing understanding of the
complexities of the metabolism of Ins 1,4,5-P8 and a successful purification of many enzymes
involved, including the ATP-dependent 3-kinase that converts Ins 1,4,5-P8 to Ins 1,3,4,5-P4, the role
of Ins 1,3,4,5-P4 as a putative second messenger remains enigmatic. Multiple forms of protein
kinase C have been described and the role is well established for a 1,2-diacylglycerol, the second
product of PIP2 hydrolysis, as its physiological activator. Although protein kinase C has been
shown to phosphorylate and modulate the activity of several proteins involved in the Ca2' signal-
ing pathway and Ca2+ transport, the physiological significance of the protein kinase C in agonist-
stimulated cell function requires further elucidation. The extension ofmeasurements ofhormone-
induced Ca2+ changes to single cells has shown that the occurrence of Ca2+ oscillations is a
common phenomena. Elucidation ofthe biochemical mechanisms causing this oscillatory response
and its physiological significance represents an important challenge for future studies.
Introduction
The cytosolic free Ca2" concentration functions as
an important intracellular signaling mechanism
whereby hormones and growth factors regulate many
different cellular processes such as secretion, metabo-
lism, neurotransmitter release, cell growth, and dif-
ferentiation. Signal transduction by the ligand-
activated receptor is mediated by specific guanine
nucleotide binding proteins (G-proteins), which acti-
vate phospholipase C-mediated hydrolysis of
phosphatidylinositol 4,5-bisphosphate (PIP2) in the
plasma membrane. The products of this reaction are
1,2-diacylglycerol, which is retained in the plasma
membrane, and D-myo-inositol-1,4,5-trisphosphate
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(Ins 1,4,5-P3). Both compounds act as intracellular
messengers with different functions.
Ins 1,4,5-P3 is responsible for mobilizing intracellu-
lar Ca2", thereby causing a rapid increase of cytosolic
free Ca2". This is transient because of an activation of
Ca2" efflux mechanisms in the plasma mem-
brane-notably the Ca2+-ATPase. In addition, recep-
tor occupancy is associated with an enhanced influx
of Ca2", which maintains the cytosolic free Ca2" above
resting levels for the duration of the agonist response
(1,2).
Diacylglycerol activates a Ca2' and phospholipid-
dependent kinase, termed protein kinase C, and pro-
motes its translocation to the plasma membrane (3,4).
Protein kinase C has short-term modulatory effects
mediated by protein phosphorylation at the level of
the receptor-G-protein complex and at post receptor
sites involving Ca2" transport and Ins 1,4,5-P3
metabolism. It also has long-term effects on secretion
and the regulation of the expression of a number ofWILLIAMSONAND MONCK
gene products involved in cell growth (5,6). These lat-
ter effects may be mediated by protein kinase C
isozymes that are different from those responsible for
the short-term effects (7-9).
Despite a general acceptance of the overall
sequence of events responsible for linking receptor
activation to increases of cytosolic free Ca2" (10-13),
many details of the mechanisms underlying each step
remain unresolved. Recent advances suggest a high
level of cellular diversification and the presence of an
intricate network of positive and negative controls
providing continuous regulation of the response elic-
ited by receptor activation.
This review will describe recent findings concern-
ing various types of novel G-proteins and
phospholipases found in different cells, and the mech-
anisms involved in regulation of Ca2' flux across the
plasma and intracellular membranes. These mecha-
nisms, together with a variety of feedback controls,
could account for diverse cellular Ca2+ responses seen
in different tissues, as well as the marked heterogene-
ity of response seen in single cells within a popula-
tion, including an oscillatory behavior of the Ca2'
signal.
Generation of Intracellular Second
Messengers
The feature that appears to be common to different
cell types for agonist-induced Ca21 mobilization
involves an interaction in the plasma membrane
between three different types of proteins, namely,
receptors, G-proteins, and phospholipase C. Most cells
contain many different types of receptors in the
plasma membrane which, upon stimulation by suita-
ble agonists, cause an increase of cytosolic free Ca2'
(10,14-16). The number of receptors and their affinity
determines the relative sensitivity of the cell to each
agonist and the extent of phospholipase C activation.
Since a particular agonist is often capable of interact-
ing with several different subtypes of receptors, the
specificity of signal transduction is likely to be deter-
mined by the nature and properties of the G-protein
that interacts with a particular receptor subtype and
effector system (17).
The Role of G-Proteins in Activating
Phospholipases
The structure and molecular properties of G-pro-
teins and their role in signal transduction have been
reviewed recently (18,19). Those involved in receptor
coupling in the plasma membrane act as both on/off
switches and a mechanism for signal channelling and
amplification. Generally they are present in greater
abundance than the receptor proteins. G-proteins
typically have a heterotrimeric apy structure. The a-
subunit is the site for GTP-binding, and differences in
their primary structure (20-23) provides the basis for
their specific roles as transducing agents. A general
model for G-protein action has been proposed, which
is based on numerous studies concerned with the
mechanism of activation of adenylate cyclase and
photoreceptor function (18,24). Binding of agonist to
the receptor causes the exchange of guanosine
diphosphate (GDP) for guanosine triphosphate (GTP)
on the G-protein a-subunit. This is accompanied by a
dissociation of the a-subunit from the heterotrimer
and a decreased binding affinity of the agonist to the
receptor. The activated (GTP-bound) a-subunit then
interacts with and modifies the activity of the effec-
tor protein. The G-protein a-subunits have an intrin-
sic GTPase activity, yielding inactive a-GDP
complexes, which reassociate with the available pool
of Py-dimers to reform the heterotrimeric G-protein,
which can then undergo further cycles of activation-
deactivation with signal amplification. Different
forms of P- and -y-subunits also exist, but the primary
role of the more lipophilic Py complexes, or myristoy-
lated a-subunits, (25) might be to anchor the G-pro-
tein in the membrane, possibly adjacent to a
particular receptor subtype.
Several properties of the G-proteins provide useful
tools for investigating their functional role in cellular
processes. Nonhydrolyzable GTP analogues such as
GTPyS cause a persistent activation of G-proteins,
but GDP,S, which mimics GDP, is inhibitory.
Another property of the G-protein a-subunits is their
susceptibility to ADP-ribosylation by bacterial tox-
ins. Cholera toxin catalyses ADP-ribosylation at an
arginine site of several G-proteins, and pertussis
toxin causes ADP-ribosylation at a cysteine site,
located near the carboxyl terminus, and uncouples the
G-protein from the receptor. The a-subunits of differ-
ent G-proteins may be ADP-ribosylated by cholera or
pertussis toxins (18). Notably, the G-protein responsi-
ble for stimulating adenylate cyclase (Gs) is a sub-
strate for cholera toxin, while the G-protein
associated with inhibition of adenylate cyclase (Gi),
and a G-protein prevalent in brain (Go) are sub-
strates for pertussis toxin.
The original evidence leading to the conclusion that
G-proteins are involved in receptor coupling of Ca2+-
mobilizing agonists to PIP2 breakdown was reviewed
recently (12,19,26,27). The basic observations are that
G-protein activating agents such as GTP, GTPyS or
AlF3 (which mimics GTP binding) when added to
permeabilized cells or plasma membrane prepara-
tions cause an activation of phospholipase C and a
decrease of agonist binding affinity. Further evidence
is provided by a) the enhancement of phospholipase C
activation by suboptimal concentrations of GTPyS in
the presence of agonist, b) an agonist-induced stimu-
lation of GTPase activity, c) the inhibition of
phospholipase C activation by GDP,S, d) an inhibi-
tion of agonist-induced activation of phospholipase C
by toxins (some cell types only), and e) the retention
of receptor-G-protein complexes (28-30) or G-protein-
phospholipase C complexes (31) during purification.
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Current evidence suggests that a variety of differ-
ent types of G-proteins are responsible for regulating
receptor coupling to phospholipase C in different cell
types. This was first suggested by the fact that ago-
nist-mediated stimulation of inositol phosphate for-
mation and Ca2' mobilization could be inhibited by
pertussis toxin pretreatment in some cell types, but
not others [for references and details of cell types see
(26)]. Ca2' mobilization induced by activation of dif-
ferent receptors can also be selectively inhibited by
pertussis toxin pretreatment in the same cell type. In
hepatocytes, epidermal growth factor (EGF)
responses are pertussis-toxin sensitive, whereas those
to vasopressin or angiotensin II are not (32). In plate-
lets, pertussis toxin inhibits thrombin but not U46619
(a thromboxane A2 analogue) responses (33). Further,
heterogeneity in the type of G-protein able to couple
to phospholipase C is suggested by the ability of chol-
era toxin to inhibit the effects ofCa2'-mobilizing ago-
nists in a variety of cell types (27,34-37). This effect of
cholera toxin was independent of ADP-ribosylation of
G. and changes of cyclic AMP.
A number of novel G-proteins that may be involved
in coupling to phospholipase C have been identified in
various cells. In neutrophils and human leukemia HL-
60 cells (30, 38-40), a pertussis toxin-sensitive 40 kDa
a-subunit has been purified and shown to be immuno-
logically distinct from the a-subunits of Go and Gi.
The copurification of this 40 kDa polypeptide with the
chemoattractant receptor suggests that it is responsi-
ble for activation of phospholipase C (30). This same
40 kDa a-subunit from HL60 cells is ADP-ribosylated
by cholera toxin in the presence of the Ca2'-mobiliz-
ing chemotatic peptide fMet-Leu-Phe, as well as by
pertussis toxin (34,35).
A pertussis toxin-sensitive 40 kDa a-subunit has
been isolated from brain (41) and shown to be struc-
turally and immunologically similar to Gia40 from
neutrophils and HL-60 cells (21,22). Reconstitution
studies performed by adding Gi or Go prepared from
brain to plasma membranes from HL-60 cells previ-
ously treated with pertussis toxin showed that they
were equally effective in restoring fMet-Leu-Phe plus
GTP-stimulated formation of inositol phosphates
(42). Addition of Go or Gi also restored bradykinin-
dependent activation of GTPase and inhibition of
adenylate cyclase in membranes from NG108-15 cells
treated with pertussis toxin (43). Furthermore, Go or
Gi stimulated the activity of partially purified
phospholipase C from platelet membranes (44). These
results suggest an apparent promiscuity of G-protein
coupling to phospholipase C, but since the prepara-
tions of Go or Gi used in these experiments probably
contained Ga40, it seems more likely that this G-pro-
tein, which also stimulates phospholipase C activity
(44), provides specificity for G-protein-phospholipase
C coupling.
A different pertussis toxin target protein with an
apparent molecular mass of 43 kDa has been partially
purified from human erythrocytes (45). This protein
has the properties expected for a G-protein a-subunit
and is also present in membranes from brain, GH4C1
pituitary cells, leukocytes, and liver (45). A 54 kDa
protein that was ADP-ribosylated by pertussis toxin
and that copurified with an inositol lipid specific
phospholipase C has been identified in the cytosolic
fraction of thymocytes (31), while a pertussis toxin
insensitive GTP-binding protein was found associated
with purified vasopressin receptors in rat liver
(28,29). Some indirect evidence suggests the possibil-
ity that an unidentified pertussis toxin sensitive G-
protein may be involved in inhibiting phospholipase C
(32,46,47). Several members of a group of G-proteins
with Mr values betwen 20,000 and 25,000, including
the well-characterized p21 ras oncogene product (48),
have been purified but their possible function in rela-
tion to inositol lipid metabolism has not been eluci-
dated (see 49).
In summary, growing evidence suggests that sev-
eral different G-proteins are responsible for activat-
ing phospholipase C. A number of novel G-protein a-
subunits have been identified by protein purification,
and multiple forms of Gi- and Go-like a-subunits with
high-sequence homology have been identified by
cDNA cloning (20,21) and by reaction with different
antibodies (22,50,51). These studies also indicate that
the Gia41 that couples with receptors to inhibit adeny-
late cyclase activity is unlikely to activate
phospholipase C. A new G-protein a-subunit has been
identified from molecular cloning of cDNA, which is
Gi-like but has a lower sequence homology than other
known G-protein a-subunits. This subunit is particu-
larly interesting because it lacks the cysteine site at
the carboxyl terminus for ADP-ribosylation by per-
tussis toxin (52,53). If this G-protein is found to be
widely expressed, it may account for pertussis toxin
insensitivity of receptor coupling to phospholipase C
observed in many tissues.
Phospholipases as G-Protein Effector
Enzymes
Several inositol lipid-specific phospholipase C
enzymes have been found in both the soluble and
plasma membrane fractions of the cell (53). Mem-
brane-bound phospholipase C has been purified after
detergent solubilization from brain, with a molecular
mass of 150 to 154 kDa (55,56); 61 kDa and 62 kDa
enzymes have been purified from platelets (57) and
uterus (58), respectively. Molecular cloning and deter-
mination of the complete amino acid sequence has
been achieved for a number of phosphatidylinositol-
specific phospholipase C enzymes from brain (59-62)
and uterus (63), which show a remarkable lack of
sequence homology. Generally, these enzymes will
hydrolyse phosphatidylinositol (PI), phosphatidyli-
nositol 4-phosphate (PIP), and PIP2 at high Ca2" con-
centrations, but they are more active toward PIP and
PIP2 at CA2+ concentrations below 10 gM. Forms of
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phospholipase C, apparently specific for PI and not
for polyphosphoinositides, have also been recognized
(64,65). As shown in intact membrane preparations
from a number of cell types, the major effect of acti-
vated G-protein on PIP2-specific phospholipase C
activity is to decrease the Ca21 concentration required
for enzyme activity to the physiological level of about
0.1 iM (66-69). In platelets, where most of the
phospholipase C activity is recoverable from the solu-
ble cell fraction, the partially purified enzyme is stim-
ulated by GTPyS (70-72). In contrast, soluble
phospholipase C from liver is not stimulated by
GTPyS (69). At present, it remains an open question
whether or not G-protein a-subunits in some tissues
may dissociate from the membrane after receptor
activation and, subsequently, interact with intracellu-
lar effector enzymes (73).
Some tissues also contain a phospholipase C spe-
cific for phosphatidylcholine, which appears to be
coupled to receptors by an unidentified G-protein
(74,75). Other types of phospholipase C specific for a
PI-glycan structure involved in membrane-anchored
proteins and insulin action have been described [see
(76) for review]. Since diacylglycerol is produced by
the action of all the different types of phospholipase
C, it is evident that protein kinase C can be activated
in the absence of Ins 1,4,5-P3-induced Ca21
mobilization.
G-proteins also control the hydrolysis of other
lipids by coupling to phospholipase D (77,78) and
phospholipase A2 (79-81), which produce phosphatidic
acid and arachidonic acid, respectively. Of the range
of products from phospholipid hydrolysis, only Ins
1,4,5-P3 is firmly established as a physiological mes-
senger for Ca2' release, although future studies may
clarify the roles postulated for arachidonic acid (82)
and phosphatidic acid (77) as Ca2+-releasing agents.
However, further metabolism of arachidonic acid to
eicosenoids such as thromboxane A2 (33) and the C6-
sulfidopeptide leukotrienes (83) causes Ca21 mobiliza-
tion by their receptor coupling to phospholipase C. It
thus appears that cells contain a heterogeneity of
phospholipase effector enzymes as well as G-proteins,
which further suggests the possibility that chemical
signaling from different receptors is uniquely chan-
neled to specific effector enzymes.
Regulation of Ins 1,4,5-P3 Production
In the intact cell Ins 1,4,5-P3 is formed together
with small amounts of the 1,2 cyclic isomer only by
phospholipase C-mediated hydrolysis of PIP2 (see 84
for review). The amount of PIP2 that is available for
hydrolysis is only sufficient to maintain Ins 1,4,5-P3
production for a few minutes. However, this hor-
mone-sensitive PIP2 pool is rapidly replenished via
PIP from part of the much large PI pool by the action
of PI and PIP kinases (11,12). These enzymes exist in
multiple forms, and there is evidence that some types
are activated by tyrosine kinases (85) or by protein
kinase C (86). The large PI pool and the high activity
of the enzymes synthesizing PIP2 mitigates against
the regulation of Ins 1,4,5-P3 production by a limita-
tion of substrate availability.
The production of Ins 1,4,5-P3 is subject to several
kinds of feedback regulation. A rapid inhibition of
agonist-induced Ins 1,4,5-P3 production and Ca2" sig-
naling is observed in many cell types by phorbol
ester-induced activation of protein kinase C
(3,10,12,79). This interaction can either be at the
receptor or a post-receptor site. Some receptors, nota-
bly a1-adrenergic and EGF receptors, are phosphoryl-
ated by protein kinase C with decreased agonist
binding and prevention of agonist-mediated signal
transduction to the G-proteins. (87). Phosphorylation
of the a1-adrenergic receptor by agonists has been
demonstrated in DDT1 MF-2 smooth muscle cells (88).
The purified a1-adrenergic receptor is also phospho-
rylated by protein kinase C (89). Receptor phospho-
rylation, however, does not seem to be a general
mechanism for phorbol ester (PMA)-induced inhibi-
tion of agonist effects. Thus, an additional post-recep-
tor site for protein kinase C-mediated interaction is
suggested from studies with plasma membrane prep-
arations. These showed no effect of PMA pretreat-
ment on agonist binding affinity nor the ability of
GTP analogues to suppress high-affinity agonist
binding (90), but they did show an inhibitory effect on
GTPyS-stimulated hydrolysis of PIP2 (90,91). Since
the production of Ins 1,4,5-P3 as well as Ca21 mobiliza-
tion is inhibited by the activation of protein kinase C,
the site for the post-receptor interaction is thought to
be at the G-protein-phospholipase C complex.
Although several G-protein a-subunits (notably
Gia41) have been shown to be phosphorylated by pro-
tein kinase C (92,93), clear evidence for the phospho-
rylation of an a-subunit functionally coupled to
phospholipase C is presently lacking. Purified
pholpholipase C from uterine smooth muscle can be
phosphorylated by protein kinase C, but the ability to
hydrolyze PIP2 was unaffected (58). Resolution of the
different mechanisms responsible for regulating Ins
1,4,5-P3 production by activating protein kinase C will
undoubtedly be aided by isolating and reconstituting
functional receptor-G-protein phospholipase C com-
plexes and using selective protein kinase C inhibitors
in intact cells.
Regulation of Ins 1,4,5-P3 Metabolism
Ins 1,4,5-P3 is rapidly metabolized to products that
do not release Ca2" from intracellular stores. Recent
studies concerned with elucidating the pathway of
inositol phosphate metabolism have shown that Ins
1,4,5-P3 is both dephosphorylated and further phos-
phorylated (84). Ins 1,4,5-P3 is degraded to Ins 1,4-P2
by both membrane-bound and soluble 5-
phosphomonoesterases having Km values of 3 to 18
,uM (94), and it is also metabolized by a calmodulin-
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dependent 3-kinase to Ins 1,3,4,5-P4. The enzyme cata-
lyzing this reaction has recently been purified from
the soluble fraction of rat brain and has a Km for Ins
1,4,5-P3 of 0.2 to 0.4 ,uM (95). The concentration of Ins
1,4,5-P3 in resting cells is equivalent to about 0.1 giM,
although this may be mostly protein-bound, and it
increases maximally during agonist stimulation to 1
to 2 jM (96,97). The low Km of the Ins 1,4,5-P3-kinase
thus favors the formation of Ins 1,3,4,5-P4.
The accumulation of Ins 1,4,5-P3 in cells after ago-
nist stimulation is typically biphasic, with a peak
increase occurring within 10 to 15 sec, whereas the
rate of PIP2 hydrolysis is linear for several minutes.
Two feedback effects increase the rate of Ins 1,4,5-P3
metabolism. The increased cytosolic free Ca2+caused
by Ins 1,4,5-P3-induced intracellular Ca2" release pro-
motes the formation of Ins 1,3,4,5-P4 by Ca2' activa-
tion of the calmodulin-dependent Ins 1,4,5-P3 3-kinase
(95,98,99). This enzyme appears to be activated by
protein kinase C (100), while the 5-phosphomonoes-
terase has also been shown to be phosphorylated and
activated by protein kinase C (101). However, there is
some doubt whether or not the latter effect occurs in
the intact cell, since the inhibition of protein kinase-C
in platelets by staurosporine had no effect on throm-
bin-induced increases of inositol phosphates (102).
Ins 1,3,4,5-P4 is hydrolyzed to Ins 1,3,4-P3 by the
membrane-bound 5-phosphomonesterase, and it com-
petitively inhibits Ins 1,4,5-P3 hydrolysis; Ins 1,3,4-P3
can be both hydrolyzed (to Ins 3,4-P2) by an inositol
polyphosphate 1-phosphomonoesterase, and phospho-
rylated to Ins 1,3,4,6-P4 by an ATP-dependent,
calmodulin-insensitive 6-kinase (84). These inositol
phosphates and their hydrolysis products have been
shown to accumulate in various cells after agonist
stimulation (103,104) with kinetics slower than those
for Ins 1,4,5-P3. The isomeric specificity of the inositol
monophosphates formed are useful in characterizing
relative flux through the different branches of the
inositol phosphate metabolic pathway (84,103). Thus,
Ins-i-P is formed primarily from the breakdown of
PI; Ins-4-P is formed from the Ins 1,4-P2 hydrolysis
produced, either directly from PIP breakdown or
from Ins 1,4,5-P3 hydrolysis. Ins-3-P reflects degrada-
tion of Ins 1,3,4,5-P4 and flux through the Ins 1,4,5-P3
phosphorylation branch. Some of the inositol
polyphosphate metabolites of Ins 1,4,5-P3, notably Ins
1,3,4,5-P4, may have second messenger functions, as
described later.
Intracellular Ca2+ Mobilization
The Hormone-Sensitive Ca2` Pool
Recent evaluations of the tissue distribution of
total Ca2+ between the cytosol and the different
organelles have led to the conclusion that the bulk of
the sequestered Ca2+ is in the endoplasmic reticulum
(105,106). It is also generally accepted that this pool
represents the source of the Ca2+ released by Ca2+-
mobilizing agonists. However, the endoplasmic retic-
ular structures are themselves heterogeneous, as are
the pools of sequestered Ca2". This is revealed by the
fact that, in numerous studies after adding agonists
to intact cells or Ins 1,4,5-P3 to permeabilized cells
and isolated microsomal preparations, only a fraction
of the sequestered Ca2" is released (10). Recent studies
have, in fact, suggested that a morphologically dis-
crete organelle termed the calciosome, which gener-
ally copurifies with endoplasmic reticulum
membranes, may represent the source of hormone
releasable Ca2" in nonmuscle cells (107). In some cells,
such as smooth muscle (108), and Limulus photore-
ceptors (109), the sites for Ca2" release may be adja-
cent to the plasma membrane. In Xenopus oocytes,
both shallow and deep injections of Ins 1,4,5-P3 caused
a local release of Ca2 , suggesting that Ins 1,4,5-P3-
sensitive Ca2` pools are distributed throughout the
cell (110,111). For most cell types, however, the distri-
bution and morphology of Ins 1,4,5-P3-sensitive Ca2"
pools have not been established. The mitochondria
are not involved in Ins 1,4,5-P3-mediated Ca21 release,
but respond to the increased cytosolic free Ca2' by a
net uptake of Ca2` and an increase of the matrix-free
Ca2+ concentration with consequent activation of
mitochondrial dehydrogenases (e.g., a-ketoglutarate
dehydrogenase) and respiration (112,113).
Sequestration of Ca2" by the endoplasmic reticulum
occurs by an ATP-driven Ca2" pump. A high-affinity
Ca2+-ATPase with a molecular mass of 116 kDa and a
Km for Ca21 of 0.1 to 0.2 jM has been purified from
liver (114) and other tissues (106). This enzyme
belongs to the class of E1P.E2P-ATPases and is bio-
chemically, kinetically, and immunologically similar
to the enzyme in skeletal muscle sarcoplasmic reticu-
lum (115). In some cell types it is also calmodulin-
dependent (106). As with sarcoplasmic reticulum, the
Ca21 sequestered by the endoplasmic reticulum is in
equilibrium between free and bound forms. It is of
considerable interest that calsequestrin (the major
Ca2+-binding protein of sarcoplasmic reticulum with a
Kd for Ca21 of 100 gM) or a similar protein has
recently been detected in the endoplasmic reticulum
of nonmuscle cells (115), including the calciosome
(107). The total amount of Ca2+-binding protein in the
vesicular compartments presumably provides a limit
to the amount of Ca21 that can be accumulated. The
free Ca21 concentration in the endoplasmic reticulum
has not been measured directly, but is probably two to
three orders of magnitude higher than that in the
cytosol, in order to provide a suitable electrochemical
gradient for rapid Ca2' efflux via opening of the Ins
1,4,5-P3-sensitive Ca21 channel. The rate of Ca21
uptake into liver microsomes is inhibited by the
intravesicular Ca21 concentration with an apparentKi
of 250 to 300 jM (116), presumably by inhibiting the
dissociation of Ca2+ from the phosphoenzyme. This
effect probably accounts for the stimulation of
MgATP-dependent Ca2+ accumulation into liver
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microsomes by glucose 6-phosphate, which on hydrol-
ysis with liberation of inorganic phosphate in the
lumen, augments the intravesicular Ca2"-buffering
capacity (117).
The endoplasmic reticulum Ca2" pump of pancreatic
acinar cells has been shown to be activated after hor-
monal stimulation with a two fold increase of Vmax for
Ca2" uptake and a decrease of the Kd for Ca2" from
0.26 to 0.09 tM (118). Evidence obtained with
saponized platelets suggests that the activation of
protein kinase C may account for a similar stimula-
tion of Ca2" sequestration after thrombin addition
(119). If the Ins 1,4,5-P3-sensitive Ca21 pool is distrib-
uted throughout the cell in discrete vesicular com-
partments, it is expected that with submaximum
agonist stimulation, there would be a heterogeneous
population of Ca2"-depleted and nondepleted vesicles,
depending on their spatial location and possible gra-
dients of Ins 1,4,5-P3 concentration within the cell.
Therefore, an activation of the Ca2' pump by either a
Ca2+/calmodulin mechanism or by a protein kinase C-
mediated phosphorylation may augment the Ca2" con-
tent of both Ins 1,4,5-P3-sensitive and Ca2"-insensitive
pools. Since the activation of the Ca21 pump by the
protein kinase C mechanism could persist after the
initial Ca21 transient, the Ca2" pools may be refilled
from the extracellular Ca2' pool without a simultane-
ous increase of the cytosolic free Ca2 , as occurs when
an agonist is displaced from its receptor (120-124).
Ins 1,4,5-P3-Induced Ca2" Release
The ability of Ins 1,4,5-P3 to release Ca21 from
intracellular, nonmitochondrial, vesicular stores
appears to be a ubiquitous property of cells. Its role in
activating many hormonal responses and in stimulus-
secretion coupling is firmly established (10). It is also
involved in excitation-contraction coupling in smooth
muscle, but whether Ins 1,4,5-P3 is similarly involved
in skeletal muscle is doubtful (125). The amount of
Ca2' released by maximal concentrations of Ins 1,4,5-
P3 is variable with different cell types, being 20 to
50% of the total cellular Ca2' content (10,126). How-
ever, the increase of the cytosolic free Ca21 is limited
to about 1 gM because of the presence of a variety of
Ca2+-binding proteins in the cytosol (106). The Ca21-
buffering capacity in the cytosol of neutrophils, for
instance, has been estimated to be 0.76 mM, with an
average dissociation constant of 0.55 jM (127). The
peak increase of the cytosolic free Ca21 occurs within
a few seconds of its initiation.
Except for one report (123), the formation of Ins
1,4,5-P3 has been shown to occur prior to or simulta-
neously with the increase of cytosolic free Ca2' after
addition of agonists to intact cells (10,12). It is impor-
tant to note, however, that the density of certain
receptor types in a given cell may be so high that
agonist stimulation causes an accumulation of Ins
1,4,5-P3 far in excess of the amount required for a
maximal release of Ca2". Thus, with vasopressin stim-
ulation of of hepatocytes, the peak increase of Ins
1,4,5-P3 accumulation occurs after the peak of the
cytosolic free Ca2" (12), whereas in other cells [e.g.,
A431 carcinoma (129)], the accumulation of Ins 1,4,5-
P3 is more transitory and appears to correlate with a
transient rise and fall of the cytosolic free Ca2". Stud-
ies using a stopped-flow measurement of the cytosolic
free Ca2" with the fluorescent Ca2" indicator Fura-2
after agonist addition in parotid acinar cells (130) and
platelets (131) have shown a lag of 100 to 200 msec
before the onset of the Ca2' increase. This lag is con-
sistent with a required short delay in the sequence of
steps involved in generating Ins 1,4,5-P3. Measure-
ment of Ca21 changes with Fura-2 in groups of single
hepatocytes by fluorescent videomicroscopy showed
that individual cells responded to vasopressin or al-
adrenergic stimulation only after a variable latent
period of up to 45 sec, which was diminished by
higher agonist concentrations (132). A similar effect
has been observed in single adrenal glomerulosa cells
after addition of angiotension II (133). These data are
consistent with a requirement for the accumulation of
a threshold concentration of a mediator in the signal-
ing pathway, possibly determined by a variable den-
sity of receptors in each cell.
Investigations concerning the mechanism of Ins
1,4,5-P3-induced Ca2' release have provided evidence
in favor of a ligand-gated Ca21 channel, with the
charge imbalance associated with Ca2' efflux from
the vesicular pool being compensated by an influx of
K+ through tetraethylammonium-sensitive K+ chan-
nels (134-136). Further evidence for a Ca21 channel
rather than a cation-exchange mechanism is provided
by the temperature insensitivity of Ins 1,4,5-P3-acti-
vated Ca2+ efflux, as measured with permeabilized
cells or microsomal fractions (134,137,138). More
direct evidence for an Ins 1,4,5-P3-gated Ca21 channel
has been obtained from electrophysiological studies
after incorporation of microsomal proteins into lipid
bilayers at the tips of patch-clamped micropipettes
(140). Currently, the nature and properties of the
reconstituted Ca2+ channels need to be defined, and it
is not known if Ins 1,4,5-P3 has any effect on
microsomal K+-channel activity.
Studies with permeabilized basophilic leukemia
cells, in which the rate of Ins 1,4,5-P3-mediated Ca2`
release was measured with Fura-2, have indicated
that channel opening was sensitive to Ins 1,4,5-P3 at
concentrations below 10 nM and was highly coopera-
tive (141). Furthermore, the Ins 1,4,5-P3-mediated
Ca2+ release mechanism is inhibited by sulfhydryl
reagents, heparin, and the Ca21 channel block-
ers-cinnarizine and flunarizine-but not by dan-
trolene, nifedipine, verapamil, diltiazem, or TMB-8
(134,142). The release of Ca2' by Ins 1,4,5-P3 is not
affected by vanadate or quercetin, which inhibit the
Ca2+ ATPase, or by caffeine, and it is independent of
the presence of ATP (143). A photoaffinity derivative
of Ins 1,4,5-P3 has been shown to inhibit Ins 1,4,5-P3-
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induced Ca2" release in permeabilized macrophages
(144), while a monoclonal antibody raised against
platelet microsomal proteins inhibited thrombin (plus
GTP) and Ins 1,4,5-P3-induced Ca2' release in mixed
dense tubular system vesicles and plasma membranes
from platelets (145). As studied in permeabilized cells,
Ins 1,4,5-P3-mediated Ca2" release does not become
desensitized (126,146).
In preparations of microsomes from some tissues,
notably liver (141), addition of Ins 1,4,5-P3 produces a
negligible release of Ca2', although a large fraction of
the sequestered Ca2" can be released by Ins 1,4,5-P3 in
microsomal fractions from other tissues (146-148)
and saponin-permeabilized hepatocytes (149). Dawson
(150) first showed that the Ins 1,4,5-P3-stimulated
Ca2" release by liver microsomes was greatly
enhanced by an addition of polyethylene glycol and
low concentrations of GTP. It subsequently became
evident that GTP itself promoted Ca2' release with
variable facilitation by polyethylene glycol and by a
separate mechanism from Ins 1,4,5-P3-induced Ca2"
release (137,151-154). GTP has been reported to pro-
mote fusion between microsomal vesicles, which cor-
related with the rate of GTP-mediated Ca2" release
(151). On the other hand, Nicchitta et al. (153) showed
that GTP induced a nonspecific permeability of the
liver microsomal membrane. The GTP effect on Ca21
release in liver microsomes is associated with a poly-
ethylene glycol-promoted increase of GTPase activity
(155), suggesting the involvement of a GTP-binding
protein. In contrast to the effects of GTP-yS on G-
proteins involved in receptor signaling, GTP-yS inhib-
its the GTPase activity and GTP-mediated Ca2"
release (155).
Experiments with permeabilized neuronal and
smooth muscle cell lines showed that Ins 1,4,5-P3
released Ca2" from the same pool as GTP, while GTP
also released Ca2" from an additional nonmitochon-
drial pool (156). In further studies, Gill and his col-
leagues suggested that uptake of Ca21 into the Ins
1,4,5-P3-sensitive Ca2' pool is controlled by a GTP-
regulated Ca21-translocating mechanism (157). In
permeabilized hepatocytes, under certain conditions
GTP enhanced the Ins 1,4,5-P3-induced Ca2" release
(158). At present, the physiological significance of the
GTP effect is not clear. Although it is unlikely that
GTP activates a specific Ca2" channel, it is possible
that through the mediation of an intracellular GTP-
binding protein, the GTP may unmask Ins 1,4,5-P3-
binding sites, increase the size of the Ins 1,4,5-P3-
sensitive Ca2' pool, or be involved in the translocation
of the calciosomes closer to the plasma membrane
where Ins 1,4,5-P3 is generated.
In a number of studies using membrane fractions
derived from liver, adrenal cortex, macrophages, neu-
trophils, anterior pituitary, and brain (159,160) the
density and affinity of Ins 1,4,5-P3 binding sites have
been characterized. Several reports indicate that
plasma membrane-enriched fractions of liver (159)
and platelets (161) contain a higher density of Ins
1,4,5-P3-binding sites than do fractions derived from
the endoplasmic reticulum. These findings are consis-
tent with the proposal that Ins 1,4,5-P3-binding and
Ca2+ release occur in specialized organelles (calci-
osomes) that are not physically or functionally part of
either the plasma or endoplasmic reticular mem-
branes. The specificity of different inositol
phosphates to displace radiolabeled Ins 1,4,5-P3 from
these binding sites is similar to their relative potency
in causing Ca2` release, namely Ins 1,4,5-P3 > Ins
2,4,5-P3> Ins 4,5-P2 > Ins 1,4-P2, Ins P5, Ins P6. Other
inositol phosphates such as Ins 1,3,4-P3 and Ins
1,3,4,5-P4 were 1 to 5% as effective as Ins 1,4,5-P3 in
causing a displacement of bound Ins 1,4,5-P3. The
number of binding sites for Ins 1,4,5-P3 is higher in
the cerebellum, compared with other parts of the
brain (162), and is about 100 times greater than that
observed in peripheral tissues. The half-maximum
binding (40-80 nM) in cerebellar membranes (160) is
also higher than values of 1 to 10 nM reported in
other tissues (159). Thus, there is an apparent, large
discrepancy between these low values for half maxi-
mum Ins 1,4,5-P3 binding and the half maximum con-
centration of Ins 1,4,5-P3 (0.1 to 2 FM) required to
release Ca2+ from permeabilized cells or isolated
microsomes (10). Several factors are known to affect
the Ins 1,4,5-P3 binding affinity that may account for
this apparent discrepancy. Notably, Ins 1,4,5-P3 bind-
ing is lower at physiological pH than at the more
alkaline pH values typically used for binding studies
(160) and is also inhibited by ATP (159). Furthermore,
the transient nature of the Ca2' release elicited by Ins
1,4,5-P3 in permeabilized cells and membrane prepa-
rations reflects its further metabolism to relatively
inactive products, so that the Ins 1,4,5-P3 concentra-
tions present in the medium might be overestimated.
The Ins 1,4,5-P3 receptor has recently been purified
from rat cerebellum using a heparin affinity column
(163). This solubilized membrane protein was shown
to have a molecular mass of 260 kDa by SDS-PAGE
and to bind Ins 1,4,5-P3 with a Kd of 100 nM at pH 8.3.
In contrast to studies with cerebellar membrane frac-
tions, where Ca2+ was shown to inhibit Ins 1,4,5-P3
binding with a half-maximal effect at 300 nM (160),
the binding of Ins 1,4,5-P3 to the purified receptor was
unaffected by Ca21 (163). The Ca2+ sensitivity is
apparently conferred by a separate protein present in
solubilized brain membranes having an estimated Mr
of 300,000 by gel filtration (164). The effect of Ca21 in
cerebellar membranes is to decrease the affinity of
Ins 1,4,5-P3 binding to the receptor (165). An increase
of extravesicular Ca2' in the range from 1 to 10 jM
has been shown to inhibit Ins 1,4,5-P3-induced Ca2+
release in permeabilized neuronal cells and micro-
somes (137,166). In studies with cerebellar micro-
somes, the concentration of Ca2+ required for
inhibition was lower at suboptimal Ins 1,4,5-P3 con-
centrations (165). Feedback inhibition by Ca2+ to
decrease the affinity of Ins 1,4,5-P3 binding to the
receptor might provide a mechanism for generating
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oscillations in cytosolic Ca2" concentration without
changes in Ins 1,4,5-P3 concentration. (See later
section.)
Ca2" Efflux from the Cell
An early event following stimulation of cells by
Ca2"-mobilizing agonists is an increased efflux of
Ca2", with a consequent fall in the total cellular Ca2"
content (1,2,16). Evidence with hepatocytes has indi-
cated that the onset of net Ca2" efflux is delayed by 5
to 10 sec after agonist addition, indicating that there
is an initial inhibition of the plasma membrane Ca2+
efflux pump (167). The mechanism of this effect has
not been ascertained, but it may relate to the altered
inositol lipid environment of the Ca2+-ATPase (168) or
to a direct inhibitory effect of Ins 1,4,5-P3 (169). Sub-
sequently, however, this inhibition is overcome so
that Ca2+ efflux is stimulated above the resting rate.
This can be attributed partly to the Ins 1,4,5-P3-
induced increase of cytosolic free Ca2 , which stimu-
lates the calmodulin-dependent plasma membrane
Ca2+-ATPase and the electrogenic Na+/Ca2+
exchanger. The latter system is present in the plasma
membrane of many cells (170). The removal of
extracellular Na+ has been shown to inhibit agonist-
stimulated Ca2` efflux in some cells such as arterial
smooth muscle (171), but not in others, such as plate-
lets (172). However, in most cells, the efflux of Ca2' by
the Ca2+-ATPase probably predominates. A net loss of
Ca21 from the cell occurs over the first few minutes
until there is a balance between the rate of Ca2' efflux
and the agonist-stimulated rate of Ca2+ influx (122).
The loss of Ca21 from the Ins 1,4,5-P3-sensitive Ca21
pool makes the cell unresponsive to further Ca21
mobilization by additional agonist stimulation until
the pool is refilled from the extracellular medium.
The Ca2+ efflux rate is not solely dependent on the
cytosolic free Ca21 concentration since the rate of
exchange of Ca2' across the plasma membrane is
increased to 2- to 4-fold during the sustained phase of
the Ca2+ transient when the cytosolic free Ca2" is only
slightly elevated above control levels (1). Studies of a
variety of cells have indicated that activation of pro-
tein kinase C by phorbol esters stimulates Ca2' efflux
(172-174). The mechanism of this effect has been
investigated by studies with the erythrocyte Ca2+-
ATPase, which showed that calmodulin increased the
Vmax 14-fold with a 4-fold decrease of the Km to 0.3
gM, while the addition of activated protein kinase C
independently increased the Vmax by 5- to 7-fold with-
out changing the Km (175).
A Ca2+-independent activation of the Ca2+-ATPase
by protein kinase C may thus account for the higher
Ca2+ efflux rate in cells after prolonged agonist stimu-
lation compared with control cells, despite the small
elevation of cytosolic free Ca2+. This dual regulation
of the Ca2+-ATPase by Ca2+/calmodulin and by pro-
tein kinase C, together with different contributions of
the Na+/Ca2" exchanger to Ca2" efflux, probably
accounts for the many detailed differences in the
relative duration and shape of the Ca2` transient
observed upon addition of different agonists to vari-
ous cell types.
Extracellular Ca2+ Mobilization
A sustained hormonal response requires an influx
of extracellular Ca2` to maintain an elevated cytosolic
free Ca2+ concentration. Evidence for an agonist
dependent stimulation of Ca2" influx is based on the
dependence of the sustained phase upon extracellular
Ca2' and an increase of unidirectional 45Ca2` influx
(1,2). The temporal relationship between intracellular
Ca2+ release and stimulated influx appears cell spe-
cific, since rapid kinetic measurements show that the
onset of stimulated Ca2` influx occurs at least as rap-
idly as intracellular Ca2" release in parotid cells (130)
and platelets (131). In A10 smooth muscle (132) and
GH3 pituitary (176) cells, stimulated Ca2+ influx
occurs after the transient intracellular Ca2+ release.
There is a 10,000-fold concentration gradient of
Ca2+ across the plasma membrane, which requires a
strict regulation of its permeability to Ca2 . Several
types of voltage-sensitive Ca2` channels that open
with membrane depolarization have been well charac-
terized (177). In some secretory cells-notably GH3
pituitary (176) and adrenal glomerulosa cells
(121)-Ca2+ entry by voltage-sensitive Ca2+ channels
may contribute towards the sustained phase of the
agonist-induced Ca2+ transient. However, in other
cells such as hepatocytes (178), the response to Ca2+
mobilizing agonists may be associated with a
hyperpolarization because of a secondary Ca2+ activa-
tion of K+ and Cl- channels. Alternatively, agonist-
induced Ca2" entry is considered to be regulated by a
process usually referred to as a receptor-operated
Ca2` channel. This entry of Ca21 is only inhibited by
agents that block voltage-sensitive Ca2` channels
when they are added at very high concentrations
(120). In fact, several mechanisms may mediate acti-
vation of Ca2` channels by receptor occupation. One
mechanism is by direct ligand activation, which
appears to occur with the ATP-activated high conduc-
tance cation channel in smooth muscle (179). Another
mechanism is by receptor-activated G-proteins, which
have been demonstrated to regulate several types of
K+ and Ca2` channels in a variety of cells (reviewed in
180). Evidence consistent with a role for a G-protein
in activating receptor operated Ca2+ channels is sug-
gested from the observations that pretreatment with
pertussis toxin inhibited Ca2+ influx, which was
induced by vasopressin in hepatocytes (181) and by
angiotensin II in adrenal glomerulosa cells (182), but
did not affect intracellular Ca2+ mobilization. A non-
selective cation channel activated by a rise of
cytosolic free Ca2+ has been reported (183,184), but in
most cells the onset of Ca21 influx does not lag behind
intracellular Ca2` mobilization. Stimulated Ca2+
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influx persists after the initial Ca2" transient, and it
is dependent on receptor occupancy, rather than on
the cytosolic free Ca2' concentration (120,121,123,185).
An attractive possibility that has generated consid-
erable attention is that Ins 1,4,5-P3, itself, or one of its
metabolic products may be responsible for agonist-
stimulated Ca2" influx. Ins 1,4,5-P3-induced Ca2"
release has been demonstrated in Na+-loaded plasma
membrane vesicles from platelets (161). Mitogenic
stimulation of T lymphocytes has been shown to be
associated with activation of a low conductance volt-
age-independent Ca2" channel in the cell-attached
patch, which could be directly activated by Ins 1,4,5-
P3 after excision of the patch (186).
An involvement of Ins 1,3,4,5-P4 in mediating Ca2'
influx was first suggested from microinjection experi-
ments with sea urchin eggs (187). Further studies
showed that there was no effect of Ins 1,3,4,5-P4 on
Ca2' influx, but at high concentrations, it induced
release of intracellular Ca2' (188). Experiments with
Xenopus oocytes showed that an injection of Ins
1,3,4,5-P4stimulated an oscillatory Ca2"-activated
chloride current at concentrations 20-fold greater
than those required for Ins 1,4,5-P3 to elicit a similar
response and also activated a voltage-sensitive Ca2'
channel, particularly after a priming injection of Ins
1,4,5-P3 (189). Measurements of whole-cell current
with voltage-clamped lacrimal acinar cells (190),
where acetylcholine in the presence of extracellular
Ca2' evokes a sustained hyperpolarization of the
plasma membrane by increasing an outward Ca2'-
activated K+ current, showed that the sustained
response required the presence of both Ins 1,4,5-P3
and Ins 1,3,4,5-P4 as well as extracellular Ca2 . In
other studies, an inward current due to nonspecific
cation channels was evoked by injection of Ins 1,3,4,5-
P4 or Ins 1,3,4-P3 into NG108-15 neuronal cells. Unlike
Ins 1,4,5-P3 injection, these compounds failed to elicit
the outward Ca2"-activated K+ (191). In contrast,
studies with NIE-115 neuroblastoma cells showed
that injection of Ins 1,3,4,-P3, but not Ins 1,3,4,5-P4,
produced a membrane depolarization in 50% of the
cells tested (192).
In summary, it must be concluded that there is
insufficient evidence to deduce the mechanism for
receptor-dependent Ca2+ entry into cells, although it
is likely that different mechanisms may predominate
in different cell types. Whether Ins 1,3,4,5-P4 or
another inositol phosphate are involved remains an
open question. Specific Ins 1,3,4,5-P4 binding sites
have been demonstrated in membranes of several tis-
sues that are distinct from Ins 1,4,5-P3 binding sites
(193,194), but their function has not yet been
ascertained.
Oscillations in Cytosolic Free Ca2+
In contrast to the many studies with bulk cell sus-
pensions where agonist-induced Ca2+ transients are
typically biphasic, the development of methods for
measuring changes of Ca2' in single cells has revealed
that the response may be oscillatory. Measurements
with the bioluminescent protein, aequorin, in single
hepatocytes stimulated with agonist showed a series
of periodic increases in cytosolic free Ca2' to above
600 nM, each returning to resting levels within 7 sec
(195,196). The frequency of these oscillations was a
function of phenylephrine concentration, with a
period varying from 20 to 240 sec. Low concentrations
of vasopressin and angiotensin II, which produce non-
saturating amounts of Ins 1,4,5-P3, caused similar
oscillations, suggesting that the occurrence of Ca2+
oscillations is favored when tissue Ins 1,4,5-P3 concen-
trations are low. In contrast, Fura-2 loaded hepato-
cytes rarely exhibit Ca2' oscillations after addition of
agonists (132). However, in other cell types, oscilla-
tions of the cytosolic free Ca2' in a proportion of cells
have been observed using Fura-2 as the Ca 2+ indica-
tor. For example, BC3H-1 cells stimulated with
phenylephrine exhibited a burst of Ca2` spikes that
ceased after several minutes (197), low concentrations
of angiotensin II-elicited Ca2' oscillations in adrenal
glomerulosa cells (133) and macrophages induced to
spread onto a suitable substratum (frustrated phago-
cytosis) showed Ca2' oscillations (198). In parotid aci-
nar cells a damped series of oscillations could be
evoked by carbachol, but in a concentration-indepen-
dent manner (199); rat peritoneal mast cells stimu-
lated with antigen responded variably with one, two,
or more spikes of increased Ca2' (200). Similarly, the
addition of carbamylcholine to insulinoma HIT (T-15)
cells loaded with Fura-2 produced a series of charac-
teristic but damped Ca2` oscillations in each respond-
ing cell (201). In general, measurements of Ca2` with
Fura-2 show a more transient, irregular pattern of
Ca2' fluctuations than those obtained with aequorin
and with a smaller proportion of cells generating
oscillations.
The difference between the data obtained with
aequorin and Fura-2 even in the same cell type, sug-
gest that they may arise from the different properties
of the Ca2' indicators. Since Fura-2 is a Ca2+ chelator,
it is possible that it diminishes the peak rise of the
Ca2' transients, which may be part of a negative feed-
back interaction responsible for generating the oscil-
lations. On the other hand, the nonlinear relationship
betwen aequorin bioluminescence and Ca2' concentra-
tion may amplify spatially localized oscillations of
Ca2'. Thus, a series of transient, localized increases in
Ca2' might be detected by aequorin as large, transient
spikes, decaying rapidly as Ca2+ diffuses into the
remainder of the cytosol, whereas Fura-2 might not
detect such a response because of its lower sensitivity
to local changes of the Ca2` concentration. However,
sustained Ca21 oscillations have been observed in
oocytes after fertilization using either Ca2+-selective
microelectrodes (202) or aequorin to measure the Ca2`
changes (203).
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Indirect evidence for oscillations of the cytosolic
free Ca21 in response to Ca21-mobilizing hormones has
been obtained from electrophysiological measure-
ments of the oscillatory behavior of Ca2"-activated K+
and Cl- channels. In HeLa cells, histamine stimulated
a pattern of Ca2+-dependent channel activation, char-
acterized by a series of bursts, which were separated
by silent periods. These correlated with membrane
potential oscillations and occurred in the absence of
extracellular Ca21 (204). Similarly, a1-adrenergic
stimulation of voltage-clamped guinea pig hepato-
cytes induced oscillatory membrane conductance
increases to K+ and Cl-, which were attributed to
Ca2+-activated K+ and Cl- channels (205). A close cor-
relation between oscillatory Ca2"-activated K+ chan-
nel activity and intracellular Ca2' has been reported
in hamster oocytes (202), with similar responses being
observed after injection of GTPyS (206).
Mechanisms for the generation of Ca21 oscillations
appear to fall into two categories: oscillations that
occur secondary to spontaneous action potentials, as
in some secretory cells (207), and oscillations induced
by Ca21-mobilizing hormones. The latter can be initi-
ated in the absence of extracellular Ca2 , indicating
that intracellular Ca2' release is the primary source
of Ca2+, although extracellular Ca2' is required for
their maintenance (197,198,204,205). A minimum
oscillating system requires a feedback loop; for sus-
tained oscillations, some delay step is required to gen-
erate the periodicity (208). Theoretically, oscillations
in the Ins 1,4,5-P3 concentration could be produced by
a negative feedback effect on the receptor or the G-
protein coupled to activation of phospholipase C by
protein kinase C. The delay step could be caused by a
slow rate of activation of the G-protein or of protein
kinase C by diacylglycerol. However, such a mecha-
nism involving a periodically activated protein kinase
C is difficult to reconcile with the decrease in the
frequency of the Ca21 oscillations observed by addi-
tion of exogenous diacylglycerol or phorbol ester to
hepatocytes (209). Furthermore, in guinea pig hepato-
cytes, oscillations in Ca2+-dependent ion conductances
could be induced by an injection of Ins 1,4,5-P3, sug-
gesting that changes in the Ins 1,4,5-P3 concentration
are not required (205). A possible mechanism for neg-
ative feedback is suggested by the inhibitory effect of
Ca2+ on Ins 1,4,5-P3 binding to its receptor, as
described earlier. Also, the time required for reac-
cumulation of Ca21 into the Ins 1,4,5-P3-sensitive pool
could provide the delay to generate a characteristic
periodicity.
In summary, there is good evidence that some oscil-
latory Ca2+ response occurs in stimulated cells. Oscil-
lations are only seen in single cells, since individual
cells in suspensions respond asynchronously. Possible
advantages of a periodic frequency-modulated signal,
compared to a graded amplitude-modulated signal,
include protection from desensitization or preventing
mitochondrial Ca21 overload (196). An alternative
possiblility is suggested by an analogy with neural
transmission where a self-propagating action poten-
tial allows transmission of information over dis-
tances. There is considerable evidence that cells are in
communication with each other through gap junc-
tions (210), which is also suggested by the synchroni-
zation of oscillations in the intact perfused liver (211).
If oscillations at low frequency induced in one cell
facilitate responses in adjacent cells, the overall tis-
sue response would be increased. Should such a mech-
anism exist, the regulation of gap junction
permeability by a variety of agents (210) would enable
fine modulation of the sensitivity of the tissue
response.
Summary
The involvement of inositol lipid metabolism in
agonist-mediated Ca2" signaling by Ins 1,4,5-P3 has
become firmly established. Recent advances have led
to a better understanding of the proteins associated
with signal transduction in the plasma membrane. A
number of specific receptors, G-proteins,
phospholipases, and inositol lipid kinases have now
been purified and characterized. An Ins 1,4,5-P3
receptor has also been purified, which is presumably
involved in mediating the Ca2" efflux from intracellu-
lar stores. The morphological site of the hormone-
sensitive Ca2" pool has been tentatively identified as
discrete, specialized intracellular structures (calci-
osomes); however, further studies are required to
demonstrate that these contain Ins 1,4,5-P3-gated
Ca2" channels. Receptor occupancy by Ca2"-mobilizing
agonists also stimulates Ca2" entry into the cell, but
the mechanism for the activation of voltage-insensi-
tive Ca2" channels and the possible involvement of Ins
1,4,5-P3, Ins 1,3,4,5-P4 and/or G-proteins in this pro-
cess has not been established.
The Ca2" signaling pathway is subject to multisite
feedback regulation by Ca2", itself, and by a diacylg-
lycerol-mediated activation of protein kinase C.
Potential sites for Ca2" interaction are displacement
of Ins 1,4,5-P3 from its receptor by a Ca2"-dependent
mechanism, promotion of Ins 1,3,4,5-P4 formation by
the Ca2+/calmodulin-regulated Ins 1,4,5-P3 3-kinase
and efflux of Ca2" from the cell, or sequestration into
intracellular Ca2" stores by Ca2+/calmodulin-regu-
lated Ca2+-ATPases. Protein kinase C activation
potentially affects the rate of generation of Ins 1,4,5-
P3 by negative feedback to the receptor-G-protein-
phospholipase C transduction system and possibly
also the rate of Ins 1,4,5-P3 removal by activation of
an inositol polyphosphate 5-phosphomonoesterase
and/or Ins 1,4,5-P3 3-kinase. It may also attentuate
the Ca2" transient directly by increasing the activity
of Ca2+-ATPases associated with the plasma mem-
brane and the endoplasmic reticulum. Cell-to-cell het-
erogeneity in the relative control strengths of these
different mechanisms may explain the differences in
the Ca2" signal in different tissues and even in differ-
ent cells within a population. The ability of Ca2" andHORMONE EFFECTS ON CELLULAR Ca2+ FLUXES 131
protein kinase C to provide negative feedback at vari-
ous points in the signal transduction pathway sug-
gests that a complex mechanism involving multiple
feedback loops is likely to regulate the generation of
Ca2" oscillations seen in some cells. The precise inter-
actions between these feedback mechanisms and the
crosstalk with other intracellular signaling pathways
enables each cell to respond in an appropriate and
unique manner.
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